The Obesity ETF – NASDAQ:SLIM
The Obesity ETF stock price today
The Obesity ETF key metrics
Market Cap | 11.33M |
Enterprise value | N/A |
P/E | N/A |
EV/Sales | N/A |
EV/EBITDA | N/A |
Price/Sales | N/A |
Price/Book | N/A |
PEG ratio | N/A |
EPS | N/A |
Revenue | N/A |
EBITDA | N/A |
Income | N/A |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | 0% |
Oper. margin | 0% |
Gross margin | 0% |
EBIT margin | 0% |
EBITDA margin | N/A |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeThe Obesity ETF stock price history
The Obesity ETF stock forecast
The Obesity ETF financial statements
The Obesity ETF other data
-
What's the price of The Obesity ETF stock today?
One share of The Obesity ETF stock can currently be purchased for approximately $33.25.
-
When is The Obesity ETF's next earnings date?
Unfortunately, The Obesity ETF's (SLIM) next earnings date is currently unknown.
-
Does The Obesity ETF pay dividends?
No, The Obesity ETF does not pay dividends.
-
How much money does The Obesity ETF make?
The Obesity ETF has a market capitalization of 11.33M.
-
What is The Obesity ETF's stock symbol?
The Obesity ETF is traded on the NASDAQ under the ticker symbol "SLIM".
-
What is The Obesity ETF's primary industry?
Company operates in the Financial Services sector and Asset Management - Global industry.
-
How do i buy shares of The Obesity ETF?
Shares of The Obesity ETF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
When The Obesity ETF went public?
The Obesity ETF is publicly traded company for more then 9 years since IPO on 8 Jun 2016.
-
How can i contact The Obesity ETF?
The Obesity ETF can be reached via phone at 877-335-2687.
The Obesity ETF company profile:
NASDAQ
0
Asset Management - Global
Financial Services
The investment seeks investment results that correspond generally to the performance, before fees and expenses, of an index which is designed to track the performance of companies globally that are positioned to profit from servicing the obese, including biotechnology, pharmaceutical, health care and medical device companies whose business is focused on obesity and obesity related disease and companies focused on weight loss programs, weight loss supplements, or plus sized apparel. The fund invests at least 80% of its net assets in the stocks that comprise the Solactive Obesity Index. It is non-diversified.
CIK: 0001500604
:
:
